E1AF inhibitors are a class of chemical compounds designed to target and inhibit the function of E1AF, also known as Ets-1-associated factor, which is a transcription factor belonging to the ETS (E26 transformation-specific) family. E1AF plays a crucial role in regulating gene expression by binding to DNA sequences known as ETS-binding sites, influencing cellular processes such as cell proliferation, differentiation, and apoptosis. The inhibition of E1AF is particularly of interest because of its role in modulating the activity of multiple genes involved in various cellular pathways. Structurally, E1AF inhibitors are diverse, comprising small molecules, peptides, and other organic compounds that can interact with the transcription factor to block its DNA-binding activity or disrupt its interactions with other proteins necessary for its function. These inhibitors may act by various mechanisms, such as binding to the ETS domain, altering the transcription factor's conformation, or interfering with its ability to localize to the nucleus where gene regulation occurs.
The development and study of E1AF inhibitors are mainly driven by the desire to understand the specific contributions of E1AF to cellular processes and to elucidate the pathways regulated by this transcription factor. These inhibitors are valuable tools for probing the molecular mechanisms behind E1AF's involvement in cellular signaling and gene regulation. By modulating the activity of E1AF, researchers can study the downstream effects on gene expression, protein-protein interactions, and cellular phenotypes. Additionally, the specificity of these inhibitors is a key factor in understanding the precise role of E1AF within the broader context of the ETS transcription factor family, as ETS proteins often have overlapping and redundant functions. Consequently, E1AF inhibitors provide an important resource for dissecting the complex regulatory networks of transcription factors and enhancing our understanding of gene expression modulation at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Inhibits the EGFR tyrosine kinase, subsequently affecting downstream signaling pathways that E1AF could be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that disrupts PI3K/AKT signaling, impacting transcription factors including those associated with E1AF activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1, which is part of the MAPK/ERK pathway, leading to reduced transcriptional activity of E1AF-related genes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, altering AP-1 activity, which can interact with E1AF and modulate its transcriptional regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, affecting transcription factors and signaling pathways that can regulate E1AF activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent PI3K inhibitor that disrupts various signaling pathways, potentially affecting the cellular processes involving E1AF. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can alter the translation of proteins and signaling pathways associated with E1AF function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that changes chromatin structure, potentially impacting E1AF-related gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to the demethylation and activation of genes, potentially affecting E1AF expression. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that disrupts cell cycle progression, potentially influencing E1AF by altering the cellular context for its activity. | ||||||